DK662688A - Farmaceutisk formulering - Google Patents

Farmaceutisk formulering

Info

Publication number
DK662688A
DK662688A DK662688A DK662688A DK662688A DK 662688 A DK662688 A DK 662688A DK 662688 A DK662688 A DK 662688A DK 662688 A DK662688 A DK 662688A DK 662688 A DK662688 A DK 662688A
Authority
DK
Denmark
Prior art keywords
pharmaceutical formulation
acrivastine
formulations
copolymer
acrylic
Prior art date
Application number
DK662688A
Other languages
English (en)
Other versions
DK662688D0 (da
DK175660B1 (da
Inventor
Harry Philip Jones
Robert Judson Mackey
Michael John Desmond Gamlen
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK662688D0 publication Critical patent/DK662688D0/da
Publication of DK662688A publication Critical patent/DK662688A/da
Application granted granted Critical
Publication of DK175660B1 publication Critical patent/DK175660B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK198806626A 1987-03-27 1988-11-25 Farmaceutisk formulering DK175660B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB878707416A GB8707416D0 (en) 1987-03-27 1987-03-27 Pharmaceutical formulations
GB8707416 1987-03-27
PCT/GB1988/000232 WO1988007369A1 (en) 1987-03-27 1988-03-25 Pharmaceutical formulations
GB8800232 1988-03-25

Publications (3)

Publication Number Publication Date
DK662688D0 DK662688D0 (da) 1988-11-25
DK662688A true DK662688A (da) 1988-11-25
DK175660B1 DK175660B1 (da) 2005-01-10

Family

ID=10614818

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198806626A DK175660B1 (da) 1987-03-27 1988-11-25 Farmaceutisk formulering

Country Status (21)

Country Link
US (2) US4954350A (da)
EP (1) EP0284408B1 (da)
JP (1) JP2753297B2 (da)
KR (1) KR960006067B1 (da)
AT (1) ATE69725T1 (da)
AU (1) AU606149B2 (da)
CA (1) CA1303504C (da)
DE (1) DE3866390D1 (da)
DK (1) DK175660B1 (da)
ES (1) ES2027005T3 (da)
FI (1) FI92904C (da)
GB (1) GB8707416D0 (da)
GR (1) GR3003224T3 (da)
HU (1) HU202102B (da)
IE (1) IE61166B1 (da)
IL (1) IL85872A (da)
NO (1) NO175618C (da)
NZ (1) NZ224024A (da)
PT (1) PT87082B (da)
WO (1) WO1988007369A1 (da)
ZA (1) ZA882167B (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2558396B2 (ja) * 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
US5188836A (en) * 1990-07-27 1993-02-23 Warner-Lambert Company Sustained release formulations
EP0520119A1 (de) * 1991-06-17 1992-12-30 Spirig Ag Pharmazeutische Präparate Neue orale Diclofenaczubereitung
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5681585A (en) 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US7070806B2 (en) * 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5514655A (en) * 1993-05-28 1996-05-07 Abbott Laboratories Enteral nutritional with protein system containing soy protein hydrolysate and intact protein
US6103262A (en) * 1994-01-27 2000-08-15 G. D. Searle & Company Modified-release metronidazole compositions and methods for making and using same
US6245351B1 (en) 1996-03-07 2001-06-12 Takeda Chemical Industries, Ltd. Controlled-release composition
ZA984336B (en) * 1997-05-21 1998-11-30 Warner Lambert Co Non-sedating acrivastine product
AU8293498A (en) 1997-07-02 1999-01-25 Euro-Celtique S.A. Stabilized sustained release tramadol formulations
JP2000128776A (ja) * 1998-10-19 2000-05-09 Asahi Chem Ind Co Ltd フィルムコーティング顆粒およびその製造方法
JP4711472B2 (ja) * 1998-10-20 2011-06-29 旭化成ケミカルズ株式会社 フィルムコーティング顆粒
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
WO2002034268A1 (fr) * 2000-10-23 2002-05-02 Ono Pharmaceutical Co., Ltd. Preparation a liberation prolongee contenant comme principe actif du trihydrochlorure de 5-acetyl-4,6-dimethyl-2-(2-(4-(2-methoxyphenyl)piperazinyl)ethylamino)pyrimidine
NZ528957A (en) * 2001-04-18 2005-05-27 Nostrum Pharmaceuticals Inc A novel coating for a sustained release pharmaceutical composition
SI1476138T1 (sl) * 2002-02-21 2012-07-31 Valeant Internat Barbados Srl Formulacije s prirejenim sproščanjem vsaj ene oblike tramadola
EP1526843A1 (en) * 2002-07-25 2005-05-04 Pharmacia Corporation Method of preparing solid dosage forms coated in two layers comprising a water-insoluble polymer and a water-soluble pore former
EP1981487B1 (en) * 2006-02-07 2014-06-25 Fmc Corporation Latex or pseudolatex compositions coatings and coating processes
WO2008135855A2 (en) 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
WO2008135828A2 (en) 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
US8974827B2 (en) 2007-06-04 2015-03-10 Bend Research, Inc. Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
US9545384B2 (en) 2007-06-04 2017-01-17 Bend Research, Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate
JP5283623B2 (ja) * 2007-07-17 2013-09-04 旭化成ケミカルズ株式会社 水系組成物
US9233078B2 (en) 2007-12-06 2016-01-12 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
WO2009073215A1 (en) 2007-12-06 2009-06-11 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
US20140295024A1 (en) * 2011-02-23 2014-10-02 Intercontinental Great Brands Llc Flavor pre-blends for chewing gum, methods of making flavor pre-blends and chewing gum compositions thereof
CA2758556A1 (en) * 2011-11-17 2013-05-17 Pharmascience Inc. Pharmaceutical composition of amphetamine mixed salts
CA2936741C (en) 2014-10-31 2018-11-06 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0052076B1 (de) * 1980-11-12 1985-05-29 Ciba-Geigy Ag Schnellzerfallende Arzneimittel-Presslinge
EP0052075A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Körnige Arzneimittel-Retardform
YU44821B (en) * 1982-02-04 1991-02-28 Wellcome Found Process for obtaiing new pyridyl derivatives
US4501893A (en) * 1982-02-04 1985-02-26 Findlay John W A 3-{6-[3-Pyrrolidino-1-(4-tolyl)prop-1-enyl]-2-pyridyl}acrylic acid and pharmaceutically acceptable salts thereof
DE3314003A1 (de) * 1983-04-18 1984-10-18 Boehringer Ingelheim KG, 6507 Ingelheim Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
LU85058A1 (fr) * 1983-10-24 1985-06-19 Pharlyse Comprimes pharmaceutiques a liberation prolongee,leur preparation et leur utilisation
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
JPH0759499B2 (ja) * 1984-02-10 1995-06-28 ベンツォン ファーマ エイ／エス 拡散被覆された複合単位服用剤
CH658188A5 (de) * 1984-03-23 1986-10-31 Ciba Geigy Ag Lagerstabile schnellzerfallende pharmazeutische presslinge.
US4871733A (en) * 1984-04-09 1989-10-03 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
GB2159715B (en) * 1984-06-04 1988-05-05 Sterwin Ag Pharmaceutical composition in sustained release unit dose form and process for its preparation
US4728512A (en) * 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
DE3681348D1 (de) * 1985-06-11 1991-10-17 Teijin Ltd Oral-arzneizubereitung mit retardwirkung.
GB8519310D0 (en) * 1985-07-31 1985-09-04 Zyma Sa Granular active substances
EP0212745B1 (en) * 1985-08-16 1991-04-10 The Procter & Gamble Company Drug particles having constant release
JPS6261916A (ja) * 1985-09-12 1987-03-18 Fujisawa Pharmaceut Co Ltd 持続性製剤
US4693896A (en) * 1985-10-07 1987-09-15 Fmc Corporation Ethylcellulose-coated, gastric-disintegrable aspirin tablet
SE450087B (sv) * 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
IT1188212B (it) * 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
US4816264A (en) * 1986-06-06 1989-03-28 Warner-Lambert Company Sustained release formulations
US4810501A (en) * 1986-06-17 1989-03-07 Warner-Lambert Company Sustained release pharmaceutical preparations
IE58401B1 (en) * 1986-06-20 1993-09-08 Elan Corp Plc Controlled absorption pharmaceutical composition
ATE71293T1 (de) * 1986-09-18 1992-01-15 London Pharmacy Innovation Arzneiformulierung.
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions

Also Published As

Publication number Publication date
FI92904B (fi) 1994-10-14
JPH01502754A (ja) 1989-09-21
DK662688D0 (da) 1988-11-25
KR960006067B1 (ko) 1996-05-08
NZ224024A (en) 1990-06-26
DE3866390D1 (de) 1992-01-09
IE880901L (en) 1988-09-27
US4954350A (en) 1990-09-04
ZA882167B (en) 1989-11-29
ES2027005T3 (es) 1992-05-16
HUT50627A (en) 1990-03-28
JP2753297B2 (ja) 1998-05-18
PT87082B (pt) 1992-07-31
US5370880A (en) 1994-12-06
EP0284408A1 (en) 1988-09-28
NO885123L (no) 1988-11-16
AU1496788A (en) 1988-11-02
IL85872A0 (en) 1988-09-30
AU606149B2 (en) 1991-01-31
CA1303504C (en) 1992-06-16
HU202102B (en) 1991-02-28
IL85872A (en) 1992-03-29
ATE69725T1 (de) 1991-12-15
KR890700344A (ko) 1989-04-24
GR3003224T3 (en) 1993-02-17
NO885123D0 (no) 1988-11-16
NO175618B (da) 1994-08-01
FI92904C (fi) 1995-01-25
NO175618C (no) 1994-11-09
FI885460A0 (fi) 1988-11-24
GB8707416D0 (en) 1987-04-29
FI885460A (fi) 1988-11-24
EP0284408B1 (en) 1991-11-27
DK175660B1 (da) 2005-01-10
PT87082A (pt) 1988-04-01
WO1988007369A1 (en) 1988-10-06
IE61166B1 (en) 1994-10-05

Similar Documents

Publication Publication Date Title
DK662688A (da) Farmaceutisk formulering
HUT56267A (en) Process for producing pharmaceutical compositions having controlled release of active ingredient
ES2080796T3 (es) Formulaciones de productos farmaceuticos de liberacion prolongada.
DE69206214D1 (de) Neue Arylethylaminderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
AU1375688A (en) Controlled release formulations
JPS57181008A (en) Novel medicine
DE69009237T2 (de) Verfahren zur Herstellung von optisch aktiven Estern der 6-t-Butoxy-3,5-dihydroxyhexansäure.
ATE73446T1 (de) Verfahren zur herstellung von chinolincarbonsaeuren.
DE3887068D1 (de) 2,2-Dimethylchromenderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
CA2044548A1 (fr) Procede d'enrobage par un polymere ph sensible de principes actifs
ATE4411T1 (de) Prostaglandin-verbindungen enthaltende pharmazeutische praeparate und verfahren zu deren herstellung.
IL85144A (en) Controlled release oral pharmaceutical compositions containing cyclic carboxylic acid esters or their polymers as carrier or coating material and their preparation
IL85776A (en) Pharmaceutical compositions comprising certain selenium containing algae and c18-c22 unsaturated acids and their preparation,used for treating conditions of the heart and cardiovascular system
TH5433EX (th) สูตรผสมในทางเภสัชกรรมของแอไครแวสทีน
NO911892D0 (no) Fremgangsmaate for fremstilling og anvendelse som medikamenter av alfa-oksopyrrol(2,3-b)indoleddiksyrer, estere, amider og beslektede analoger.
ATE104848T1 (de) Trapidil enthaltende pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung.
TH5433A (th) สูตรผสมในทางเภสัชกรรมของแอไครแวสทีน
DE68928788D1 (de) Verfahren zur Herstellung von optisch aktiven 3,4-Dihydroxybuttersäurederivaten
TH4604B (th) สูตรผสมในทางเภสัชกรรมของแอไครแวสทีน
AR002736A1 (es) Uso de ester 3-metil-5-etilico de acido 2,6-dimetil-4-(2,3-diclorofenil-1,4 -dihidropiridin-3,5-dicarboxilico (felodipina) para fabricar un medicamento ypreparacion farmaceutica para el tratamiento de la disfuncion cerebral.
ATE53993T1 (de) 1,4-dihydropyridincarbonsaeure-ester, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
PUP Patent expired